Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FRA: 496) announced that as a result of a review by the British Columbia Securities Commission (BCSC), the company has decided to withdraw and refile... read more →
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FRA: 496) announced on Friday it filed the required Business Acquisition Reports (BAR) in relation to the company's previously announced acquisitions of Artisan Growers,... read more →
The First Drug in the Psychedelics Space, Ketamine-Based Spravato By J&J Was Approved Last Year At $6,700 a Month, Spravato is Expected to Generate Well North of $1.3 Billion Annually... read more →
Medical Professionals are Beginning to Use Psychedelics to Treat a Host of Mental Disorders Champignon Brands is Growing a Vertically Integrated Psychedelic Drug Company Other Major Competitors Are Using Different... read more →